Page results
-
This information is for patients who are receiving radiotherapy to the prostate or prostate bed. It explains what the treatment involves, describes side-effects you may experience during and after treatment, and how best to cope with them.
-
Radiotherapy Department Patient Information series no. 18 - prostate brachytherapy prostate high dose rate (HDR) brachytherapy
-
ME/CFS is a condition where chronic fatigue is not, much relieved by rest. It affects daily functioning and may also trigger joint pains, mood and sleep disturbance, concentration difficulties, headaches, intestinal and urinary symptoms.
-
This information describes the different types of anaesthetic you might require for your operation.
-
The UCLH Bariatric Centre for Weight Management and Metabolic Surgery is one of the largest obesity and bariatric centres in the county, with an international reputation for the quality and expertise of our clinical service, our research and the clinical training that we provide.
-
Information about the integrated physiotherapy service at the Royal London Hospital for Integrated Medicine.
-
The Macmillan Support and Information Service have developed an online programme of workshops and videos. These give advice to support people who have cancer or a blood condition to manage well from diagnosis onwards.
-
Learn more about the Spectra Optia Funding to Deliver More Apheresis Capacity for Patients
-
As part of Together Type 1, Diabetes UK are excited to invite young people to join an engaging online ‘Type 1 Chat’.
File results
-
FOI/2023/0038 - Cases where breast milk of a new mother was given to a child who is not her own
-
FOI/2023/0041 - International recruitment
-
FOI/2023/0054 - Local formulary used at the Trust
-
FOI/2023/0058 - Skin cancer pathway management
-
FOI/2023/0063 - Women who have given birth at the Trust aged 50 or above
-
FOI/2023/0242 - Treatment of Haemophilia A
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)
-
FOI/2023/0260 - Treatment for rare diseases: Fabry, Gaucher and Pompe disease and Hunter Syndrome
-
FOI/2023/0249 - Treatments for clotting disorders - Haemophilia B, Von Willebrand Disease
-
FOI/2023/0262 - Clinical trial participation